- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04945486
The Effect of Peer-mentor Support for Older Vulnerable Patients With Ischemic Heart Disease
The Effect of a Peer-mentor Intervention on Inequality in Cardiac Rehabilitation Attendance: a Mixed Method Intervention Study Among Older Vulnerable Patients With Ischemic Heart Disease
BACKGROUND: Advanced treatment regimens have reduced cardiovascular mortality resulting in an increasingly older Ischemic Heart Disease (IHD) population in need of cardiac rehabilitation (CR) , the majority (74%) is above 60 years. The positive effect of CR is well established; CR reduces cardiovascular mortality, lowers hospital admissions, and improves quality of life among patients with IHD. These positive effects of CR has also been established among older patients. The inherent problem lies in the low attendance rate, often below 50%. Several studies, including studies from Denmark, have shown that low participation in CR is most prevalent among older, vulnerable and female patients. The notion vulnerable covers patients with low socioeconomic position (SEP), patients with non-western background and patients living alone, as these groups have particularly low CR attendance. Effective interventions aiming at increasing CR attendance among these low attending groups are thus warranted and the current study will seek to address this.
AIM: To test the effect of a peer-mentor intervention among older vulnerable IHD patients.
DESIGN AND METHODS: The study is designed as a two arm RCT-study applying mixed methods.
Power calculations were based upon primary outcome 'Cardiac rehabilitation (CR) attendance'. Proportion attending CR in control group was set at 25% and intervention group at 50% based upon previous research. With a 5% significance level and 80% power. 110 patients were required (55 in each group) to have a 80% chance of detecting, as significant at the 5% level, an increase in the primary outcome measure from 25% in the control group to 50% in the experimental group.
Expected dropout was 6%. I.e., in total 117 patients are enrolled.
Patients (n=117) are recruited by a dedicated research nurse before discharge from the cardiology department at Nordsjællands Hospital and randomized (with 1:1 individual randomisation) to peer-mentor intervention or usual care. Data is collected through both qualitative and quantitative data (mixed methods). Data is collected at three timepoints, baseline, 12 weeks and 24 weeks. The patients (mentees) are matched with peer-mentors. Peer-mentoring (i.e. mentoring by a person with a similar life situation or health problem as one self) is a low-cost intervention that holds the potential to improve CR attendance and improve physical and psychological outcomes among older patients. Peer-mentors are role models who can guide and support patients overcoming barriers of CR attendance. Peer-mentoring is unexplored in a CR setting among older, female and vulnerable IHD patients; establishing the novelty of the current study.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Frederikssund, Denmark
- Nordsjællands Hospital - Frederikssund
-
Hillerød, Denmark
- Nordsjællands Hospital - Hillerød
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- ≥65 years and diagnosed with IHD and referred to CR and female or low SEP or single living or non-western background
Exclusion Criteria:
- Patients unable to provide written consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Peer-mentoring
The patients (mentees) are matched with a peer-mentor i.e. a person with a similar life situation or health problem as one self
|
Peer-mentor support for up to 6 months
|
|
No Intervention: Usual care
Usual care provided by professional healthcare workers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiac rehabilitation attendance
Time Frame: 24 weeks
|
Measured as 'self-reported CR attendance'
|
24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Health-related Quality of Life
Time Frame: Baseline to 24 weeks
|
Measured using the 'HeartQoL' 'Health-related Quality of Life Questionnaire'.
Min.
score: 0, max score: 42.
Higher scores indicating a better outcome.
|
Baseline to 24 weeks
|
|
Change in Self-efficacy
Time Frame: Baseline to 24 weeks
|
Measured using the questionnaire 'General self-efficacy scale'.
Min score: 10, max score: 40.
Higher scores indicating a better outcome
|
Baseline to 24 weeks
|
|
Change in symptoms of anxiety and depression
Time Frame: Baseline to 24 weeks
|
Measured using the questionnaire 'The hospital anxiety and depression scale' (HADS).
Min.
score: 0, max score 42.
Lower scores indicating a better outcome
|
Baseline to 24 weeks
|
|
Change in dietary quality
Time Frame: Baseline to 24 weeks
|
Measured using the questionnaire 'Heartdiet'.
Higher scores indicating a better outcome
|
Baseline to 24 weeks
|
|
Change in physical activity
Time Frame: Baseline to 24 weeks
|
Measured using the questionnaire 'Heartdiet'.
Higher scores indicating a better outcome
|
Baseline to 24 weeks
|
|
Qualitative content of disease trajectory
Time Frame: Baseline to 24 weeks
|
Semi-structured qualitative interviews with patients (n=20-25)
|
Baseline to 24 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Alias: 200348 RCT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemic Heart Disease
-
Elumn8 MedicalEnrolling by invitationIschemic Heart Disease | Ischemic Heart Disease Chronic | Coronary Chronic Total Occlusions | Ischemic Heart Disease (IHD)United States
-
Genzyme, a Sanofi CompanyTerminatedIschemic Heart Disease | Ischemic Cardiomyopathy | Ischemic Heart FailureBelgium, France, Germany, Italy, Switzerland, United Kingdom
-
University of AlbertaActive, not recruitingCoronary Artery Disease | Stable Ischemic Heart Disease | Beta-blocker TherapyCanada
-
Yonsei UniversityRecruitingIschemic Heart Diease | Non-ischemic Heart DiseaseSouth Korea
-
Cardiocentro TicinoTerminatedChronic Ischemic Heart DiseaseSwitzerland
-
Gerencia de Atención Primaria, MadridServicio Canario de Salud; Avedis Donabedian Research InstituteCompletedIschemic Heart Disease ChronicSpain
-
Michael SekelaCompletedChronic Ischemic Heart DiseaseUnited States
-
Zoll Medical CorporationRecruitingCardiovascular Diseases | Cardiomyopathies | Heart Disease, Ischemic | Cardiomyopathy IschemicGermany
-
University of PecsCompleted
-
Rigshospitalet, DenmarkNot yet recruitingChronic Ischemic Heart DiseaseDenmark
Clinical Trials on Peer-mentor intervention
-
Nova Scotia Health AuthorityActive, not recruiting
-
Johns Hopkins Bloomberg School of Public HealthNational Institute on Drug Abuse (NIDA); Johns Hopkins UniversityCompleted
-
Johns Hopkins Bloomberg School of Public HealthCompletedHepatitis C | HIV | Risk Reduction BehaviorUnited States
-
Sunnybrook Health Sciences CentreUnity Health Toronto; University of Toronto; Mount Sinai Hospital, Canada; The... and other collaboratorsCompletedEarly Inflammatory ArthritisCanada
-
Sunnybrook Health Sciences CentreCanadian Arthritis NetworkCompletedChronic Disease | Early Inflammatory ArthritisCanada
-
University College CopenhagenHvidovre University Hospital; Amager Hospital; Herlev and Gentofte Hospital; Nordsjaellands...Not yet recruitingAtrial FibrillationDenmark
-
VA Office of Research and DevelopmentCompletedPrimary Health Care | Homeless PersonsUnited States
-
University of WashingtonCompleted
-
Indiana UniversityAcademic Model Providing Access to Healthcare (AMPATH); Indiana CTSICompletedStigma, Social | HIV Pre-exposure ProphylaxisKenya
-
Weill Medical College of Cornell UniversityCompletedCoronary Artery DiseaseUnited States